BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38378070)

  • 1. TBX15 and SDHB expression changes in colorectal cancer serve as potential prognostic biomarkers.
    Golozar M; Motlagh AV; Mahdevar M; Peymani M; InanlooRahatloo K; Ghaedi K
    Exp Mol Pathol; 2024 Apr; 136():104890. PubMed ID: 38378070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
    Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
    Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of cell surface proteins gene expression in diagnosis, prognosis, and drug resistance of colorectal cancer: In silico analysis and validation.
    Nazempour N; Taleqani MH; Taheri N; Haji Ali Asgary Najafabadi AH; Shokrollahi A; Zamani A; Fattahi Dolatabadi N; Peymani M; Mahdevar M
    Exp Mol Pathol; 2021 Dec; 123():104688. PubMed ID: 34592197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of key genes for predicting colorectal cancer prognosis by integrated bioinformatics analysis.
    Dai GP; Wang LP; Wen YQ; Ren XQ; Zuo SG
    Oncol Lett; 2020 Jan; 19(1):388-398. PubMed ID: 31897151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of hub genes in colorectal cancer based on weighted gene co-expression network analysis and clinical data from The Cancer Genome Atlas.
    Zhang Y; Luo J; Liu Z; Liu X; Ma Y; Zhang B; Chen Y; Li X; Feng Z; Yang N; Feng D; Wang L; Song X
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34308980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatic Identification of Hub Genes and Analysis of Prognostic Values in Colorectal Cancer.
    Lei X; Jing J; Zhang M; Guan B; Dong Z; Wang C
    Nutr Cancer; 2021; 73(11-12):2568-2578. PubMed ID: 33153324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of potential biomarkers with colorectal cancer based on bioinformatics analysis and machine learning.
    Hammad A; Elshaer M; Tang X
    Math Biosci Eng; 2021 Oct; 18(6):8997-9015. PubMed ID: 34814332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive analysis of the prognosis, tumor microenvironment, and immunotherapy response of SDHs in colon adenocarcinoma.
    Nan H; Guo P; Fan J; Zeng W; Hu C; Zheng C; Pan B; Cao Y; Ge Y; Xue X; Li W; Lin K
    Front Immunol; 2023; 14():1093974. PubMed ID: 36949947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival marker genes of colorectal cancer derived from consistent transcriptomic profiling.
    Martinez-Romero J; Bueno-Fortes S; Martín-Merino M; Ramirez de Molina A; De Las Rivas J
    BMC Genomics; 2018 Dec; 19(Suppl 8):857. PubMed ID: 30537927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-Cell RNA Sequencing Reveals the Role of Epithelial Cell Marker Genes in Predicting the Prognosis of Colorectal Cancer Patients.
    Shen KY; Chen BY; Gao WC
    Dis Markers; 2022; 2022():8347125. PubMed ID: 35968507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel diagnostic and prognostic biomarkers of colorectal cancer: Capable to overcome the heterogeneity-specific barrier and valid for global applications.
    Hameed Y; Usman M; Liang S; Ejaz S
    PLoS One; 2021; 16(9):e0256020. PubMed ID: 34473751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The overexpression and clinical significance of TBX15 in human gliomas.
    Yan D; Yu Y; Ni Q; Meng Q; Wu H; Ding S; Liu X; Tang C; Liu Q; Yang K
    Sci Rep; 2023 Jun; 13(1):9771. PubMed ID: 37328486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A network-based predictive gene expression signature for recurrence risks in stage II colorectal cancer.
    Yang WJ; Wang HB; Wang WD; Bai PY; Lu HX; Sun CH; Liu ZS; Guan DK; Yang GW; Zhang GL
    Cancer Med; 2020 Jan; 9(1):179-193. PubMed ID: 31724326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer.
    Yue Y; Zhang Q; Sun Z
    Front Immunol; 2021; 12():758040. PubMed ID: 35140706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of succinate dehydrogenase subunit B and up-regulation of pyruvate dehydrogenase kinase 1 predicts poor prognosis in recurrent nasopharyngeal carcinoma.
    Dai Z; Pan S; Chen C; Cao L; Li X; Chen X; Su X; Lin S
    Tumour Biol; 2016 Apr; 37(4):5145-52. PubMed ID: 26547584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effects of Differentially-Expressed Homeobox Family Genes on the Prognosis and HOXC6 on Immune Microenvironment Orchestration in Colorectal Cancer.
    Qi L; Ye C; Zhang D; Bai R; Zheng S; Hu W; Yuan Y
    Front Immunol; 2021; 12():781221. PubMed ID: 34950145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a five-gene signature with prognostic value in colorectal cancer.
    Sun G; Li Y; Peng Y; Lu D; Zhang F; Cui X; Zhang Q; Li Z
    J Cell Physiol; 2019 Apr; 234(4):3829-3836. PubMed ID: 30132881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An age stratified analysis of the biomarkers in patients with colorectal cancer.
    Yao H; Li C; Tan X
    Sci Rep; 2021 Nov; 11(1):22464. PubMed ID: 34789836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and validation of a novel signature as a diagnostic and prognostic biomarker in colorectal cancer.
    Wang D; Liufu J; Yang Q; Dai S; Wang J; Xie B
    Biol Direct; 2022 Nov; 17(1):29. PubMed ID: 36319976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments.
    Zhang T; Guo J; Gu J; Wang Z; Wang G; Li H; Wang J
    Oncol Rep; 2019 Jan; 41(1):279-291. PubMed ID: 30542696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.